Literature DB >> 25460022

Dexmedetomidine improves early postoperative cognitive dysfunction in aged mice.

Xiao-Lan Qian1, Wei Zhang2, Ming-Zheng Liu3, Yu-Bing Zhou2, Jing-Min Zhang4, Li Han4, You-Mei Peng4, Jin-hua Jiang5, Qing-Duan Wang6.   

Abstract

Postoperative cognitive dysfunction (POCD) is a frequent complication following major surgery in the elderly. However, the exact pathogenic mechanisms are still unknown. Dexmedetomidine, a selective alpha 2 adrenal receptor agonist, was revealed anesthesia and brain protective role. The present study aimed to examine whether dexmedetomdine protects against POCD induced by major surgical trauma under general anesthesia in aged mice. In the present study, cognitive function was assessed by Y-maze. Proinflammatory cytokines interleukin-1β (IL-1β) and tumor necrosis factor (TNF-α), apoptosis-related factor caspase-3 and Bax were detected by real-time PCR, Western blot or immunohistochemistry. The results showed that anesthesia alone caused weak cognitive dysfunction on the first day after general anesthesia. Cognitive function in mice with splenectomy under general anesthesia was significantly exacerbated at the first and third days after surgery, and was significantly improved by dexmedetomidine administration. Splenectomy increased the expression of IL-1β, TNF-α, Bax and caspase-3 in hippocampus. These changes were significantly inversed by dexmedetomidine. These results suggest that hippocampal inflammatory response and neuronal apoptosis may contribute to POCD, and selective alpha 2 adrenal receptor excitation play a protective role.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aged; Anesthesia; Apoptosis; Dexmedetomidine; Inflammation; Postoperative cognitive dysfunction

Mesh:

Substances:

Year:  2014        PMID: 25460022     DOI: 10.1016/j.ejphar.2014.11.017

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  26 in total

Review 1.  Neurotoxicity of anesthetics: Mechanisms and meaning from mouse intervention studies.

Authors:  Simon C Johnson; Amanda Pan; Li Li; Margaret Sedensky; Philip Morgan
Journal:  Neurotoxicol Teratol       Date:  2018-11-22       Impact factor: 3.763

2.  Shallow metabolic depression and human spaceflight: a feasible first step.

Authors:  Matthew D Regan; Erin E Flynn-Evans; Yuri V Griko; Thomas S Kilduff; Jon C Rittenberger; Keith J Ruskin; C Loren Buck
Journal:  J Appl Physiol (1985)       Date:  2020-01-30

3.  Whole transcriptome sequencing reveals dexmedetomidine-improves postoperative cognitive dysfunction in rats via modulating lncRNA.

Authors:  Fumou Deng; Lily Cai; Bin Zhou; Zhidong Zhou; GuoHai Xu
Journal:  3 Biotech       Date:  2020-04-13       Impact factor: 2.406

4.  [Dexmedetomidine alleviates cognitive dysfunction induced by tibial fracture in rats].

Authors:  Jinwei Zhang; Xiaobao Zhang; Haitao Qian; Jizheng Cui; Xiaoping Gu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-03-30

5.  Dexmedetomidine attenuates hippocampal neuroinflammation in postoperative neurocognitive disorders by inhibiting microRNA-329-3p and activating the CREB1/IL1RA axis.

Authors:  Jinquan Chen; Qian Ding; Xiangxue Jiao; Binrong Wang; Zhenzhong Sun; Yutao Zhang; Juan Zhao
Journal:  Psychopharmacology (Berl)       Date:  2022-04-12       Impact factor: 4.530

6.  Dexmedetomidine Postconditioning Reduces Brain Injury after Brain Hypoxia-Ischemia in Neonatal Rats.

Authors:  Xiaoyan Ren; Hong Ma; Zhiyi Zuo
Journal:  J Neuroimmune Pharmacol       Date:  2016-03-02       Impact factor: 4.147

7.  An investigation of the mechanism of dexmedetomidine in improving postoperative cognitive dysfunction from the perspectives of alleviating neuronal mitochondrial membrane oxidative stress and electrophysiological dysfunction.

Authors:  Jie Chen; Na Shen; Xiaohui Duan; Yaning Guo
Journal:  Exp Ther Med       Date:  2017-12-04       Impact factor: 2.447

8.  Dexmedetomidine Ameliorates Postoperative Cognitive Dysfunction via the MicroRNA-381-Mediated EGR1/p53 Axis.

Authors:  Yi-Liang Wang; Ying Zhang; Da-Sheng Cai
Journal:  Mol Neurobiol       Date:  2021-07-10       Impact factor: 5.590

9.  Elevation of miR-146a Inhibits BTG2/BAX Expression to Ameliorate Postoperative Cognitive Dysfunction Following Probiotics (VSL#3) Treatment.

Authors:  Lei Mao; Qingcui Zeng; Wenjie Su; Menglong Song; Jiacen Li; Min Xie
Journal:  Mol Neurobiol       Date:  2021-03-16       Impact factor: 5.590

10.  Dexmedetomidine post-conditioning attenuates cerebral ischemia following asphyxia cardiac arrest through down-regulation of apoptosis and neuroinflammation in rats.

Authors:  Guangqian Li; Pan Gu; Dan Fan
Journal:  BMC Anesthesiol       Date:  2021-06-28       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.